ライブラリ登録: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

年間 6 号発行

ISSN 印刷: 0743-4863

ISSN オンライン: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Bioconjugates: Harnessing Potential for Effective Therapeutics

巻 26, 発行 2, 2009, pp. 119-155
DOI: 10.1615/CritRevTherDrugCarrierSyst.v26.i2.10
Get accessGet access

要約

The accomplishment of selective delivery can be brought through efficient drug targeting in which the attack of drug moiety is visualized only by the diseased organ and not by the organs of the whole body. This, in turn, consequently minimizes the unwanted effects or side effects caused by the drug action on the other organs. Bioconjugation is a fascinating technique that explores new vistas of drug delivery, and at the same time opens new possibilities for safe and effective therapy. This review is dedicated to and describes the science of bioconjugation and its potential in the drug delivery field, including different bioconjugates and their use in various therapeutic strategies. These have been classified as polymer based, macromolecule based, carrier based, and novel bioconjugates. This review describes the utility of bioconjugates in major diseases like cancer and others, and discusses experiments and research on the same. Bioconjugates have immense potential and extend a promising future in the drug delivery field. The review can act as a quick reference for those actively engaged in drug delivery and drug research to help overcome the hurdles of therapeutics.

によって引用された
  1. Feng Zhen, Li Wenjuan, Xue Xiaomin, Geng Xu, Wu Yelin, Huang Jing, Wu Zirong, A Novel GAP460 Biopolymer for Use as a Carrier in Drug-Delivery Applications, Journal of Biomaterials Science, Polymer Edition, 22, 15, 2011. Crossref

  2. Jain Aviral, Singhai Priyanka, Gurnany Ekta, Updhayay Satish, Mody Nishi, Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brain, Journal of Nanoparticle Research, 15, 3, 2013. Crossref

  3. Clavé Guillaume, Volland Hervé, Flaender Mélanie, Gasparutto Didier, Romieu Anthony, Renard Pierre-Yves, A universal and ready-to-use heterotrifunctional cross-linking reagent for facile synthetic access to sophisticated bioconjugates, Organic & Biomolecular Chemistry, 8, 19, 2010. Crossref

  4. Brogden Nicole K., Brogden Kim A., Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?, International Journal of Antimicrobial Agents, 2011. Crossref

  5. Bidwell Gene L., Raucher Drazen, Cell penetrating elastin-like polypeptides for therapeutic peptide delivery, Advanced Drug Delivery Reviews, 62, 15, 2010. Crossref

  6. Lewis Lavinia M., Pizzo Michelle E., Sinha Sandipan, Ahmed Syed S., Joseph Liji, Visible and Sub-visible Particle Formation for a Model Bioconjugate, AAPS PharmSciTech, 18, 3, 2017. Crossref

  7. Padilla Marshall S., Farley Christopher A., Chatkewitz Lindsay E., Young Douglas D., Synthesis and incorporation of a caged tyrosine amino acid possessing a bioorthogonal handle, Tetrahedron Letters, 57, 42, 2016. Crossref

  8. Nimmo Zachary M., Halonski John F., Chatkewitz Lindsay E., Young Douglas D., Development of optimized conditions for Glaser-Hay bioconjugations, Bioorganic Chemistry, 76, 2018. Crossref

  9. Xu Yingding, Huang Wei, Ren Gang, Qi Shibo, Jiang Han, Miao Zheng, Liu Hongguang, Lucente Ermelinda, Bu Lihong, Shen Baozhong, Barron Annelise, Cheng Zhen, A Four-Arm Star-Shaped Poly(ethylene glycol) (StarPEG) Platform for Bombesin Peptide Delivery to Gastrin-Releasing Peptide Receptors in Prostate Cancer, ACS Macro Letters, 1, 6, 2012. Crossref

  10. Young Douglas D., Schultz Peter G., Playing with the Molecules of Life, ACS Chemical Biology, 13, 4, 2018. Crossref

  11. Raucher Drazen, Moktan Shama, Thermo‐Responsive Polymers, in Drug Delivery in Oncology, 2011. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain